trial · primary record
Androgen Receptor Pathway Inhibitor
Castration-Sensitive Prostate Adenocarcinoma
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2029-06-01 |
| Primary endpoint | Change in mean daily hot flash score |
| Registry ID | NCT07466498 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:54.648Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07466498
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.